2m 2m 2m 2m 2m 2m 2m
CITIUS PHARMACTC (CTXR)
NASDAQ
$0.59-$0.02 (-2.70%)
Price as of Jun 03, 2026 7:10 PM EDT- $18.0MMarket Cap
- -30.25%1-Year Change
- BiotechnologyIndustry
CITIUS PHARMACTC (CTXR)
$0.59-$0.02 (-2.70%)
CTXR | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.60 | ||
Change | -$0.03 (-4.84%) | ||
Open | $0.65 | ||
High | $0.66 | ||
Low | $0.60 | ||
Previous Close | $0.63 | ||
Volume | 450,298 | ||
30-Day Average Volume | 798,214 | ||
1-Week Change | -13.44% | ||
1-Month Change | -13.81% | ||
1-Year Change | -30.25% | ||
3-Year Change | -98.17% | ||
5-Year Change | -98.96% | ||
Fundamentals | |||
Shares Outstanding | 27.5M | ||
Total Assets | $132.5M | ||
Market Cap | $18.0M | ||
Enterprise Value | $313.4M | ||
Period: QTR TTM FY | |||
Revenue | $1.7M | ||
Net Income | -$28.1M | ||
Free Cash Flow | -$1.3M | ||
EBIT | -$28.3M | ||
EBITDA | -$28.3M | ||
Net Working Capital | -$23.3M | ||
EPS | -$0.95 | ||
Enterprise Value/EBITDA | -11 | ||
Enterprise Value/Revenue | 188 | ||
P/B | 0 | ||
P/E | -1 | ||
PEG | 0 | ||
Price/Free Cash Flow | -14 | ||
Price/Operating Cash Flow | -14 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 25 | ||
Last Split Date | 11/26/2024 | ||
Earnings & Revenue